Antibody injection promising for diabetes and obesity

(Medical Xpress) -- Researchers at Genetech Inc. in South San Francisco, California, led by molecular biologist Junichiro Sonoda, have discovered that a single injection of antibodies (against fibroblast growth factor  FGF receptors ) into obese diabetic mice provided a marked and sustained improvement in their condition and a reduction in their weight.
Enhanced by Zemanta

No comments: